Task: Answer the multiple choice question.
Query: Which drug exhibits a -1.778\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
(a) CCOC(=O)c1ccc(-n2c(=S)sc3c(=O)[nH]c(C)nc32)cc1
(b) CC1(C)Cc2c(sc3nc(C4CCCCC4)n(N)c(=O)c23)CO1
(c) O=C(COC(=O)CCc1nc2ccccc2c(=O)[nH]1)Nc1ccc(OC(F)(F)F)cc1
(d) Cn1nccc1C(=O)N1CCC(Cc2ccccc2)CC1
Answer: d. Cn1nccc1C(=O)N1CCC(Cc2ccccc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1nccc1C(=O)N1CCC(Cc2ccccc2)CC1
Cn1nccc1C(=O)N1CCC(Cc2ccccc2)CC1
(4-benzylpiperidin-1-yl)-(2-methylpyrazol-3-yl)methanone